ZOMDF
Zomedica Corp.
$0.09
0.00 (-2.63%)
At close · Jul 6
Market Cap
$90.65M
Shares
979,949,668
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.09
Open$0.09
Day$0.09–0.10
52W$0.04–0.16
Avg vol 30d1.0M
Short int126K · 0.0% float · 1.0d
Short vol6%
Last earningsMay 6, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 6
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Sell
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−12% below
−
Price vs 50-day avg
−6% below
◦
RSI (14)
47 · neutral
+
MACD trend
positive
◦
52-week position
47% · mid-range
Sentiment · smart money
Bullish
◦
Trend (MA cross)
50d $0 › 200d $0 — 200d above 50d
◦
Institutional flow
1 of 7 funds reported for Jun 30 · net 0 sh shares
◦
Insider flow
No net insider activity over 90 days
+
Short interest
0.01% of float · ▼ -0.5% MoM · 1.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
7 holders — mid 3-yr range
Fundamentals
Fair
+
Gross margin
525%
−
EPS growth
−60% Y/Y
−
Free cash flow
$-18.2M
+
Balance sheet
net cash $8.5M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
Next earnings call
Aug 1, 2026
Est · unconfirmed
· in 4 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 6, 2026
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−12% below
Bearish
Price vs 50-day avg
−6% below
Bearish
RSI (14)
47 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
47% · mid-range
Neutral
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
1 of 7 funds reported for Jun 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.01% of float · ▼ -0.5% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
7 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $0
Now $0 · 47%
52-wk high $0
vs 200-day avg -12%
vs 50-day avg -6%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Cash burn for the quarter | $5.7M | first quarter of 2026 | — |
| Engineering Services revenues | $1.2M | first quarter of 2026 | — |
| Therapeutic Device segment margin | 70% | first quarter of 2026 | — |
| Cash burn | $18.1M | the year ended December 31, 2025 | — |
| Gross margin | 68% | the year ended December 31, 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ZOMDF
this stock
Zomedica Corp.
|
$90.65M | -9.3% | +17.4% | — | 0.0% |
|
ABT
Abbott Laboratories
|
$166.17B | -23.5% | +5.7% | 26.7 | 1.3% |
|
SYK
Stryker Corp
|
$125.18B | -6.8% | +11.2% | 37.8 | 1.6% |
|
MDT
Medtronic plc
|
$106.49B | -12.7% | +8.4% | 22.3 | 1.4% |
|
BSX
Boston Scientific Corp
|
$67.09B | -52.7% | +5.5% | 18.9 | 2.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ZOMDF | -3.7% | -6.6% | -35.8% | -7.5% | -9.3% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | -5.1% | -5.3% | -43.8% | -7.2% | -18.5% |